|
ORGAN
transplants in the Philippines, including those
scheduled under the medical-tourism program, have been
temporarily held in abeyance by the Department of Health
(DOH) pending approval of a new policy being drafted
that will establish a board to set the guidelines on
organ transplantation in the country.
On
questions the medical-tourism program could suffer a
setback, Health Secretary Francisco Duque III said
Monday “kidney transplantation is not part of medical
tourism” and the administrative order on the suspension
was also meant to kill a thriving industry of illegal
organ trade that often preys on the poor.
Duque
had also ordered the creation of the Philippine Network
for Organ Donation and Transplantation (Philnetdat) that
will, among others, oversee the inspection and
accreditation of transplant facilities.
In 2006
and 2007, about 200,000 patients from foreign countries
that include the United States and its territories,
South Pacific nations,
Canada,
Korea and Japan have come to the Philippines for medical
tourism.
The
temporary ban on organ transplant for foreigners was
also done in the wake of reports that non-Filipinos are
being prioritized for the medical procedure over local
patients because donors are often paid between P100,000
and P200,000.
But a
group of militant health professionals warned that the
proposed DOH policy would only legalize and facilitate
the sale of kidney and other human organs.
The
Health Alliance for Democracy (HEAD) said the AO does
not define what it meant by “gratuity” and “acceptable
compensation” as alternatives to paying organ donors.
“Even in
broad strokes, there is no description as to how the DOH
seeks to stop kidney trade outside the creation of a
board,” said the group in a statement.
Dr. Gene
Alzona Nisperos, HEAD secretary-general, also criticized
a provision that allows a donor name the donee. “[It]
means that the donor designates the recipient, which
further cultivates a prorich bias and rampant abuse of
the poor.”
Between
10,000 and 12,500 Filipinos develop end-stage renal
disease annually and about 50 percent to 60 percent of
them are kidney-transplant candidates.
However,
less than 10 percent are given transplants because of
insufficient supply and the high cost that many patients
could not afford. |